BA/BE Studies Market Overview: The global BA/BE (Bioavailability/Bioequivalence) studies market is experiencing significant growth, driven by advances in pharmacology, rising demand for generic drug..

The global L&D market is forecasted to grow at a CAGR of 2–3 percent to $377 (E) billion and $393 billion between 2023 and 2026, respectively. The Onset of the pandemic has had a significant imp..